Internet-delivered Cognitive Behavioral Therapy (CBT) for Health Anxiety (Ha1b)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by Karolinska Institutet.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT00828152
First received: January 22, 2009
Last updated: June 16, 2010
Last verified: June 2010
  Purpose

Hypochondriasis (health anxiety) is common, has many negative consequences for the afflicted individual and is associated with high societal costs. Cognitive Behavioural Therapy (CBT) has proven to be effective when administered in live-sessions. The aim of this study is to investigate whether CBT remains effective when administered via a self-help programme on the Internet.


Condition Intervention Phase
Hypochondriasis
Behavioral: Internet-delivered CBT.
Behavioral: On line discussion group
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Internet-delivered Cognitive Behavioural Therapy for Health Anxiety - a Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Karolinska Institutet:

Primary Outcome Measures:
  • Health Anxiety Inventory [ Time Frame: 3 days before treatment start ] [ Designated as safety issue: No ]
  • Health Anxiety Inventory [ Time Frame: 12 weeks after pre asessment ] [ Designated as safety issue: No ]
  • Health Anxiety Inventory [ Time Frame: 6 months after post assessment ] [ Designated as safety issue: No ]
  • Health Anxiety Inventory [ Time Frame: 12 months after post assessment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • IAS [ Time Frame: Immediately pre and post treatment,and 6 and 12 month follow up ] [ Designated as safety issue: No ]
  • BAI [ Time Frame: Immediately pre and post treatment, and 6 and 12 month follow-up ] [ Designated as safety issue: No ]
  • MADRS-S [ Time Frame: Immediately pre and post treatment, and 6 and 12 month follow-up ] [ Designated as safety issue: No ]
  • QOLI [ Time Frame: Immediately pre and post treatment, and 6 and 12 month follow-up ] [ Designated as safety issue: No ]
  • WI [ Time Frame: Immediately pre and post treatment, and 6 and 12 month follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 80
Study Start Date: January 2009
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Internet-delivered CBT. Contact with therapist thru an e-mail system. 12 weeks.
Behavioral: Internet-delivered CBT.
12 weeks. Therapist contact through e-mail.
Placebo Comparator: 2
On line discussion group.
Behavioral: On line discussion group
Placebo. On line discussion group.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary diagnosis of hypochondriasis
  • At least 18 years old
  • Able to read and write in swedish
  • Computer access

Exclusion Criteria:

  • Drug abuse
  • Concurrent severe depression
  • No serious somatic illness
  • Previous treatment with CBT for hypochondriasis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00828152

Locations
Sweden
Psykiatri Sydväst
Stockholm, Sweden, 141 86
Sponsors and Collaborators
Karolinska Institutet
  More Information

No publications provided by Karolinska Institutet

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Nils Lindefors, Psykiatri Sydväst
ClinicalTrials.gov Identifier: NCT00828152     History of Changes
Other Study ID Numbers: Ha1b
Study First Received: January 22, 2009
Last Updated: June 16, 2010
Health Authority: Sweden: Regional Ethical Review Board

Additional relevant MeSH terms:
Hypochondriasis
Somatoform Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 20, 2014